On ECHEMI
Home > Drugs > Juvenile rheumatoid disease
Juvenile rheumatoid disease
Juvenile rheumatoid arthritis (JRA) is a common connective tissue disease in children, characterized by chronic arthritis and multiple systemic involvement, including joints, skin, muscles, liver, spleen, and lymph nodes. Younger children often have persistent irregular fever first, and their systemic symptoms are more significant than joint symptoms. Older children or adult patients are more limited to joint symptoms. The clinical manifestations of this disease vary greatly and can be divided into different types, so there are many names. Such as Still's disease (1897), juvenile rheumatoid recurrent fever type (Wissler Fanconi syndrome), juvenile chronic arthritis (juvenile chronic arthritis, JCA), juvenile rheumatoid disease (juvenile rheumatoid disease) and juvenile arthritis (juvenile arthritis, JA).
  • Site of disease:

    Joints Whole Body
  • Infectious :

    Not contagious
  • Frequent population:

    Older children or adults, more often boys
  • Related symptoms:

    Muscle atrophy Joint stiffness Remittent fever Macculopapular rash Remittent fever
  • Concurrent disease:

Related Drugs
Phenylbutazone
Indication: Used for rheumatoid arthritis, rheumatic arthritis and gout. It often needs to be given continuously or used in combination with other drugs. It is also used for acute lymphangitis caused by filariasis.
Manufacturer:

Jinan JINDA Pharmaceutical Chemistry Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.